Four injectable peptide vials bought from a Brooklyn bodega contained none of the active ingredients named on their labels, according to lab testing commissioned by Wired and carried out by the independent testing startup Finrick. Wired paid a little more than $375 for the four vials at Mister Green in June and received the results in August.

The vials were sold as "research use only" peptides, a label that Wired notes cannot legally be attached to products sold for human consumption in the United States. Peptides are amino-acid compounds widely marketed in wellness and fitness circles for weight loss and injury recovery, and Wired describes some of the benefits promoted alongside them as backed by limited evidence.

What the testing did and did not find

The samples showed low levels of heavy metals and endotoxins, so this is not a contamination story in the usual sense. It is something arguably harder to reason about: buyers were left without the substance they thought they were purchasing, or injecting, with no clear picture of what they got instead.

That gap exists because the lab only tested for the ingredients that were supposed to be there. Wired says the failures could have several explanations, including mislabeled product or degradation from poor storage, and what the vials actually contained remains unknown.

The company went dark

INDR Labs, the company named on the products, did not respond to Wired's request for comment. After being contacted, Wired says, the company placed its website behind a password.

That is not a crime, but it is a data point about how thin the accountability layer is here. "Basically anyone can open a peptide business these days, and it's really easy to buy this kind of product online and in stores," Wired reported.

Why a bodega matters

The retail setting is the part worth sitting with. A product on a shelf next to ordinary groceries reads as vetted in a way the same vial on a website does not, and Wired's framing is that visibility and popularity can make these products seem more mainstream and safer than they are.

Bottom line

Wired's case points at gaps in oversight of gray-market wellness products and in enforcement around substances not legally sold for human consumption. Independent testing is one of the few tools available for checking whether the label matches the contents, and in this instance it did not.